The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore
Open accessAbstract
OBJECTIVE: To develop and validate a new diabetes risk algorithm (the QDScore) for estimating 10 year risk of acquiring diagnosed type 2 diabetes over a 10 year time period in an ethnically and socioeconomically diverse population. DESIGN: Prospective open cohort study using routinely collected data from 355 general practices in England and Wales to develop the score and from 176 separate practices to validate the score. PARTICIPANTS: 2 540 753 patients aged 25-79 in the derivation cohort, who contributed 16 436 135 person years of observation and of whom 78 081 had an incident diagnosis of type 2 diabetes; 1 232 832 patients (7 643 037 person years) in the validation cohort, with 37 535 incident cases of type 2 diabetes. OUTCOME MEASURES: A Cox proportional hazards model was used to estimate effects of risk factors in the derivation cohort and to derive a risk equation in men and women. The predictive variables examined and included in the final model were self assigned ethnicity, age, sex, body mass index, smoking status, family history of diabetes, Townsend deprivation score, treated hypertension, cardiovascular disease, and current use of corticosteroids; the outcome of interest was incident diabetes recorded in general practice records. Measures of calibration and discrimination were calculated in the validation cohort. RESULTS: A fourfold to fivefold variation in risk of type 2 diabetes existed between different ethnic groups. Compared with the white reference group, the adjusted hazard ratio was 4.07 (95% confidence interval 3.24 to 5.11) for Bangladeshi women, 4.53 (3.67 to 5.59) for Bangladeshi men, 2.15 (1.84 to 2.52) for Pakistani women, and 2.54 (2.20 to 2.93) for Pakistani men. Pakistani and Bangladeshi men had significantly higher hazard ratios than Indian men. Black African men and Chinese women had an increased risk compared with the corresponding white reference group. In the validation dataset, the model explained 51.53% (95% confidence interval 50.90 to 52.16) of the variation in women and 48.16% (47.52 to 48.80) of that in men. The risk score showed good discrimination, with a D statistic of 2.11 (95% confidence interval 2.08 to 2.14) in women and 1.97 (1.95 to 2.00) in men. The model was well calibrated. CONCLUSIONS: The QDScore is the first risk prediction algorithm to estimate the 10 year risk of diabetes on the basis of a prospective cohort study and including both social deprivation and ethnicity. The algorithm does not need laboratory tests and can be used in clinical settings and also by the public through a simple web calculator (www.qdscore.org).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Missing data: our view of the state of the art
Schafer, J. L., & Graham, J. W. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.2.147 · Cited by 11,638
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Strong evidence from randomised controlled trials shows that behavioural or pharmacological interventions can prevent type 2 diabetes in up to two thirds of high risk cases.”
BackgroundThe Spread of Obesity in a Large Social Network over 32 Years
Christakis, N. A., & Fowler, J. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa066082 · Cited by 5,007
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
A comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
Multiple Imputation of Missing Values
Royston, P. (2004) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0400400301 · Cited by 2,340
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Cited by
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Self-citationRisk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.10001 · Cited by 1,279
Imamura, F., O’Connor, L., Ye, Z., Mursu, J., Hayashino, Y., Bhupathiraju, S. N., & Forouhi, N. G. (2015) · BMJ · doi:10.1136/bmj.h3576 · Cited by 977
Goldstein, B. A., Navar, A. M., Pencina, M. J., & Ioannidis, J. P. A. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw042 · Cited by 936
Imamura, F., O'Connor, L., Ye, Z., Mursu, J., Hayashino, Y., Bhupathiraju, S. N., & Forouhi, N. G. (2016) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-h3576rep · Cited by 956
Collins, G. S., Ogundimu, E. O., & Altman, D. G. (2016) · Statistics in Medicine · doi:10.1002/sim.6787 · Cited by 665
Riley, R. D., Ensor, J., Snell, K. I. E., Debray, T. P. A., Altman, D. G., Moons, K. G. M., & Collins, G. S. (2016) · BMJ · doi:10.1136/bmj.i3140 · Cited by 585
Risk models and scores for type 2 diabetes: systematic review
Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551
Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00316-2 · Cited by 551
Collins, G. S., Mallett, S., Omar, O., & Yu, L.-M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-103 · Cited by 484
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P., Lindström, J., Lalic, N., Greaves, C., McKee, M., Kissimova-Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 469
Hippisley-Cox, J., Coupland, C., Robson, J., & Brindle, P. (2010) · BMJ · doi:10.1136/bmj.c6624 · Cited by 364
Self-citationHippisley-Cox, J., & Coupland, C. (2012) · BMJ · doi:10.1136/bmj.e3427 · Cited by 351
Self-citationAbbasi, A., Peelen, L. M., Corpeleijn, E., van der Schouw, Y. T., Stolk, R. P., Spijkerman, A. M. W., van der A, D. L., Moons, K. G. M., Navis, G., Bakker, S. J. L., et al. (2012) · BMJ · doi:10.1136/bmj.e5900 · Cited by 321
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes
Buijsse, B., Simmons, R. K., Griffin, S. J., & Schulze, M. B. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq019 · Cited by 297
“Hippisley-Cox, 2009 (62) Cohort from general practices, United Kingdom Age, sex, BMI, smoking status, corticosteroid use, antihypertensive use, family history (7/7) Men: 0.”
BackgroundInfluentialTalmud, P. J., Hingorani, A. D., Cooper, J. A., Marmot, M. G., Brunner, E. J., Kumari, M., Kivimaki, M., & Humphries, S. E. (2010) · BMJ · doi:10.1136/bmj.b4838 · Cited by 296
Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
Sattar, N., & Gill, J. M. R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00326-5 · Cited by 259
Anjana, R. M., Shanthi Rani, C. S., Deepa, M., Pradeepa, R., Sudha, V., Divya Nair, H., Lakshmipriya, N., Subhashini, S., Binu, V. S., Unnikrishnan, R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2814 · Cited by 259
Liu, J., Davidson, E., Bhopal, R., White, M., Johnson, M., Netto, G., Deverill, M., & Sheikh, A. (2012) · Health Technology Assessment · doi:10.3310/hta16440 · Cited by 237
Self-citationHippisley-Cox, J., & Coupland, C. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x616355 · Cited by 208
Self-citationThe InterAct Consortium (2011) · Diabetologia · doi:10.1007/s00125-011-2182-9 · Cited by 208
Carrión, R. E., Cornblatt, B. A., Burton, C. Z., Tso, I. F., Auther, A. M., Adelsheim, S., Calkins, R., Carter, C. S., Niendam, T., Sale, T. G., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15121565 · Cited by 170
“A number of risk calculators are now freely available to the public and can estimate the risk, for example, of prostate, ovarian, breast, pancreatic, and colorectal cancer(4–6), type 2 diabetes(7, 8), and cardiovascular disease (9–11).”
BackgroundPredicting the onset of type 2 diabetes using wide and deep learning with electronic health records
Nguyen, B. P., Pham, H. N., Tran, H., Nghiem, N., Nguyen, Q. H., Do, T. T. T., Tran, C. T., & Simpson, C. R. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.105055 · Cited by 158
Herrington, W. G., Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D. R., Coresh, J., & Woodward, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173515 · Cited by 141
Zhang, L., Zhang, Z., Zhang, Y., Hu, G., & Chen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097865 · Cited by 130
Cichosz, S. L., Johansen, M. D., & Hejlesen, O. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815611680 · Cited by 101
Noordali, F., Cumming, J., & Thompson, J. L. (2017) · Journal of Health Psychology · doi:10.1177/1359105315620293 · Cited by 84
Hippisley-Cox, J., & Coupland, C. (2015) · BMJ · doi:10.1136/bmj.h5441 · Cited by 63
Self-citationLin, J.-W., Chang, Y.-C., Li, H.-Y., Chien, Y.-F., Wu, M.-Y., Tsai, R.-Y., Hsieh, Y.-C., Chen, Y.-J., Hwang, J.-J., & Chuang, L.-M. (2009) · Diabetes Care · doi:10.2337/dc09-0694 · Cited by 60
“Ten currently available DRSs, including the ARIC (Atherosclerosis Risk in Community Study), Asian Indian, Cambridge (UK), Danish, DESIR (Data from the Epidemiological Study on Insulin Resistance Syndrome) (French), Dutch, FINDRISC (Finnish), Oman, QDScore (UK), and Thai risk scores were analyzed (3-12).”
MethodUpdate of the German Diabetes Risk Score and external validation in the German MONICA/KORA study
Mühlenbruch, K., Ludwig, T., Jeppesen, C., Joost, H.-G., Rathmann, W., Meisinger, C., Peters, A., Boeing, H., Thorand, B., & Schulze, M. B. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.013 · Cited by 52
Staite, E., Bayley, A., Al-Ozairi, E., Stewart, K., Hopkins, D., Rundle, J., Basudev, N., Mohamedali, Z., & Ismail, K. (2020) · JMIR mHealth and uHealth · doi:10.2196/15448 · Cited by 39
Mozaffary, A., Asgari, S., Tohidi, M., Kazempour-Ardebili, S., Azizi, F., & Hadaegh, F. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010889 · Cited by 27
Li, Y., Jin, N., Zhan, Q., Huang, Y., Sun, A., Yin, F., Li, Z., Hu, J., & Liu, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1495306 · Cited by 35
“(9) The integration of interpretable algorithms, such as the Shapley additive explanation (SHAP) algorithm, to interpret risk prediction models can help clinicians better understand the key drivers behind model predictions, thereby enhancing clinical decision-making.”
Mansi, I. A., Sumithran, P., & Kinaan, M. (2023) · BMJ · doi:10.1136/bmj-2022-071727 · Cited by 20
Updated risk factors should be used to predict development of diabetes
Bethel, M. A., Hyland, K. A., Chacra, A. R., Deedwania, P., Fulcher, G. R., Holman, R. R., Jenssen, T., Levitt, N. S., McMurray, J. J. V., Boutati, E., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.012 · Cited by 12
Metadata
- Authors
- Hippisley-Cox, J., Coupland, C., Robson, J., Sheikh, A., & Brindle, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2009-03-17
- Volume
- 338
- Issue
- mar17 2
- Pages
- b880-b880
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2158810997
- Cited by
- 372
- References
- 62
- FWCI
- 21.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.